Paul M. Stewart - Concepedia

Author

Paul M. Stewart

Also Known As

Bettendorf, Daniel, Cachafeiro, Ada, Dow, Anna, Earp, JoAnne, Goldsmith, Lowell A, Grandjean, Philippe, Iwona Bujalska, M Stewart, Paul, P M Stewart, P STEWART

656

Publications

39.6K

Citations

103

H-Index

221

Concepts

All Affiliations

University of Birmingham Queen Elizabeth Hospital Birmingham University of Leeds Queen Elizabeth Hospital Western General Hospital

About

Paul M. Stewart is an author at University of Birmingham specializing in medicine, endocrinology, and metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	56	99	11.6K
2	Health Sciences	25	27	2.3K
3	Natural Sciences	7	7	1.5K
4	Engineering	5	5	209
5	Language Studies	1	1	41

Paul M. Stewart

271

Publications

30.7K

Citations

H-Index

Page 1

	Year	Citations
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline Lynnette K. Nieman, Beverly M. K. Biller, James W. Findling, The Journal of Clinical Endocrinology & Metabolism	2008	2.6K
LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR Christopher R.W. Edwards, D. Burt, Martin McIntyre, The Lancet Molecular PharmacologyAdrenal GlandMolecular PhysiologyBiochemistryThe Mineralocorticoid Receptor	1988	1.1K
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant Peter Trainer, William M Drake, Laurence Katznelson, New England Journal of Medicine	2000	865
Extrarenal Expression of 25-Hydroxyvitamin D<sub>3</sub>-1α-Hydroxylase<sup>1</sup> Daniel Zehnder, Rosemary Bland, Mary C. Williams, The Journal of Clinical Endocrinology & Metabolism	2001	848
Does central obesity reflect “Cushing's disease of the omentum”? Iwona Bujalska, Sudhesh Kumar, Paul M. Stewart The Lancet ObesityMetabolic SyndromeMetabolic DisorderDiabetesObesity Management	1997	751
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist Aart Jan van der Lely, R. Kent Hutson, Peter Trainer, The Lancet Growth HormoneHuman GrowthLong-term TreatmentDevelopmental EndocrinologyEndocrinology	2001	637
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors Wiebke Arlt, Michael Biehl, Angela E. Taylor, The Journal of Clinical Endocrinology & Metabolism	2011	449
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. Paul M. Stewart, John E. T. Corrie, C.H.L. Shackleton, Journal of Clinical Investigation HypertensionElectrolyte DisorderApparent Mineralocorticoid ExcessPotassium RetentionGlucocorticoid	1988	428
A RATIONAL APPROACH FOR ASSESSING THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS Paul M. Stewart, J. R. Seckl, John E. T. Corrie, The Lancet Adrenal GlandPituitary GlandPsychiatryHypothalamusPhysiology	1988	421
Cortisol Metabolism in Human Obesity: Impaired Cortisone→Cortisol Conversion in Subjects with Central Adiposity<sup>1</sup> Paul M. Stewart, Abigail Boulton, Sudhesh Kumar, The Journal of Clinical Endocrinology & Metabolism	1999	398

Page 1